| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| XKH-001(Xinkanghe Biomedical) | XKH-001 | Phase 2 Clinical | Beijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co Ltd | Allergic asthma; Asthma; Dermatitis, Atopic; Idiopathic Pulmonary Fibrosis; Inflammation; Pulmonary Disease, Chronic Obstructive | Details |